Table of Contents Author Guidelines Submit a Manuscript
International Journal of Endocrinology
Volume 2014, Article ID 354040, 5 pages
http://dx.doi.org/10.1155/2014/354040
Research Article

Dipeptidyl Peptidase-4 Inhibitors as a Third-Line Oral Antihyperglycaemic Agent in Patients with Type 2 Diabetes Mellitus: The Impact of Ethnicity

1Department of Endocrinology and Metabolism, The Second Hospital of Dalian Medical University, Dalian, Liaoning 116027, China
2Diabetes Centre, Royal Prince Alfred Hospital, Camperdown, NSW 2050, Australia
3School of Nursing, University of Sydney, Sydney, NSW 2006, Australia
4Discipline of Medicine, University of Sydney, Sydney, NSW 2006, Australia

Received 9 June 2014; Revised 21 July 2014; Accepted 23 July 2014; Published 10 August 2014

Academic Editor: Andre P. Kengne

Copyright © 2014 X. Zhang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

X. Zhang, B. Brooks, L. Molyneaux, et al., “Dipeptidyl Peptidase-4 Inhibitors as a Third-Line Oral Antihyperglycaemic Agent in Patients with Type 2 Diabetes Mellitus: The Impact of Ethnicity,” International Journal of Endocrinology, vol. 2014, Article ID 354040, 5 pages, 2014. https://doi.org/10.1155/2014/354040.